Registry for patients with end-stage renal disease in Lorraine

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The REIN Registry aims to improve the prevention and management of end-stage renal disease by collecting comprehensive data on patients undergoing renal replacement therapy in the Lorraine area. It includes all patients starting renal replacement therapy, documenting key events such as renal transplantation and changes in dialysis settings. The registry is supported by a network of nephrologists and public health representatives, ensuring accurate and complete data collection through regular verification visits to dialysis centers. This initiative promotes clinical and epidemiological research to enhance patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients with end stage renal disease on renal replacement therapy

Exclusion Criteria:

* Patients with acute renal failure ( i.e. those who recover all or some renal function within 45 days or are considered as such by experts when they die before 45 days)
* Patient's refusal

Where it's running

• Nephrology unit, University hospital
  Nancy, France Recruiting

Study contacts

• Principal investigator: Emmanuelle Laurain, MD — Central Hospital, Nancy, France
• Study coordinator: Carole Ayav, MD
• Email: c.ayav@chru-nancy.fr

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ribupatide PK in People with Kidney Impairment

  This study tests how a single shot of ribupatide behaves in the body for people with severe kidney problems compared to those with normal kidney function.

  Recruiting at 2 sites Phase 1 Kailera · Orlando, Florida and 1 other locations · NCT07793929

• Intradiay dialysis exercise to improve posture in adults with end-stage kidney disease

  This study tests whether a 12-week supervised exercise program done during dialysis can improve posture in adults on maintenance hemodialysis.

  Recruiting Pardis Specialized Wellness Institute · Isfahan · NCT07720401

• Pumpkin seed oil for people on hemodialysis

  This study tests whether taking pumpkin seed oil daily for 3 months helps reduce inflammation and improve-related lab markers in people with end-stage kidney disease on dialysis.

  Recruiting Al-Mustansiriyah University · Baghdad, Karkh · NCT07710183

• Porcine thymokidney transplant for end-stage renal disease

  This study tests whether a GalKO porcine thymokidney transplant can keep kidney function without dialysis in adults with end-stage kidney disease who are unlikely to get a standard donor kidney soon.

  Recruiting Phase 1 Xeno Holdings (US), LLC dba ChoironeX · New York, New York and 1 other locations · NCT07696962

• How inflammatory diseases change the way your body handles medicines.

  This study will see if inflammatory conditions like type 2 diabetes, IBD, or end-stage kidney disease change how common medicines are processed and increase the chance of side effects.

  Recruiting Indiana University · Indianapolis, Indiana · NCT07360938

• CRISPR-edited donor kidney transplant to reduce rejection risk

  This trial will see if donor kidneys edited with CRISPR to turn off key HLA genes can lower rejection in adults with end-stage kidney disease receiving transplants.

  Recruiting Phase 1/2 American Organ Transplant and Cancer Research Institute LLC · Beijing, Changping · NCT07053462

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.